These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 20359499)
1. A rotarod test for evaluation of motor skill learning. Shiotsuki H; Yoshimi K; Shimo Y; Funayama M; Takamatsu Y; Ikeda K; Takahashi R; Kitazawa S; Hattori N J Neurosci Methods; 2010 Jun; 189(2):180-5. PubMed ID: 20359499 [TBL] [Abstract][Full Text] [Related]
2. Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control. Chagniel L; Robitaille C; Lacharité-Mueller C; Bureau G; Cyr M Behav Brain Res; 2012 Mar; 228(1):9-15. PubMed ID: 22127145 [TBL] [Abstract][Full Text] [Related]
3. The effect of dopamine on MPTP-induced rotarod disability. Ayton S; George JL; Adlard PA; Bush AI; Cherny RA; Finkelstein DI Neurosci Lett; 2013 May; 543():105-9. PubMed ID: 23562518 [TBL] [Abstract][Full Text] [Related]
4. Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice. Hirst SJ; Ferger B Synapse; 2008 Feb; 62(2):85-90. PubMed ID: 17992685 [TBL] [Abstract][Full Text] [Related]
5. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490 [TBL] [Abstract][Full Text] [Related]
6. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Schumm S; Sebban C; Cohen-Salmon C; Callebert J; Launay JM; Golmard JL; Boussicault L; Petropoulos I; Hild A; Rousselet E; Prigent A; Friguet B; Mariani J; Hirsch EC J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926 [TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094 [TBL] [Abstract][Full Text] [Related]
9. Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease. Kim ST; Son HJ; Choi JH; Ji IJ; Hwang O Brain Res; 2010 Jan; 1306():176-83. PubMed ID: 19804765 [TBL] [Abstract][Full Text] [Related]
10. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction. Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947 [TBL] [Abstract][Full Text] [Related]
11. Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade. Viaro R; Marti M; Morari M Exp Neurol; 2010 Jun; 223(2):473-84. PubMed ID: 20122926 [TBL] [Abstract][Full Text] [Related]
12. Apomorphine as a neuroprotective drug: a study in MPTP-treated mice and potential relevance to ischemia. Orzi F; Castri P; Fornai F Funct Neurol; 2001; 16(4 Suppl):153-8. PubMed ID: 11996511 [No Abstract] [Full Text] [Related]
14. Dopamine-dependent motor learning: insight into levodopa's long-duration response. Beeler JA; Cao ZF; Kheirbek MA; Ding Y; Koranda J; Murakami M; Kang UJ; Zhuang X Ann Neurol; 2010 May; 67(5):639-47. PubMed ID: 20437561 [TBL] [Abstract][Full Text] [Related]
15. Short and long-term motor skill learning in an accelerated rotarod training paradigm. Buitrago MM; Schulz JB; Dichgans J; Luft AR Neurobiol Learn Mem; 2004 May; 81(3):211-6. PubMed ID: 15082022 [TBL] [Abstract][Full Text] [Related]
16. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
17. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Pallier PN; Drew CJ; Morton AJ Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400 [TBL] [Abstract][Full Text] [Related]
18. Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. Quinn LP; Stean TO; Chapman H; Brown M; Vidgeon-Hart M; Upton N; Billinton A; Virley DJ J Neurosci Methods; 2006 Sep; 156(1-2):218-27. PubMed ID: 16626808 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic agonists impair latent learning in mice: possible modulation by noradrenergic function. Ichihara K; Nabeshima T; Kameyama T J Pharmacol Exp Ther; 1993 Jan; 264(1):122-8. PubMed ID: 8093719 [TBL] [Abstract][Full Text] [Related]
20. A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease. Liebetanz D; Baier PC; Paulus W; Meuer K; Bähr M; Weishaupt JH Exp Neurol; 2007 May; 205(1):207-13. PubMed ID: 17341420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]